Total Payments
$68,282
2024 Payments
$323.55
Companies
64
Transactions
820
Medicare Patients
417
Medicare Billing
$46,666
Payment Breakdown by Category
Other$48,046 (70.4%)
Food & Beverage$13,648 (20.0%)
Consulting$3,667 (5.4%)
Travel$2,834 (4.2%)
Education$87.51 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,046 | 30 | 70.4% |
| Food and Beverage | $13,648 | 764 | 20.0% |
| Consulting Fee | $3,667 | 1 | 5.4% |
| Travel and Lodging | $2,834 | 23 | 4.2% |
| Education | $87.51 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $26,300 | 64 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $24,041 | 94 | $0 (2021) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $5,284 | 37 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $2,502 | 30 | $0 (2019) |
| ABBVIE INC. | $1,014 | 69 | $0 (2024) |
| GENZYME CORPORATION | $802.52 | 39 | $0 (2023) |
| Amgen Inc. | $703.46 | 34 | $0 (2023) |
| UCB, Inc. | $677.11 | 51 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $589.18 | 22 | $0 (2021) |
| Allergan, Inc. | $552.08 | 37 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $323.55 | 19 | ABBVIE INC. ($194.66) |
| 2023 | $1,100 | 57 | AbbVie Inc. ($311.27) |
| 2022 | $868.83 | 72 | ABBVIE INC. ($239.48) |
| 2021 | $27,407 | 136 | Biohaven Pharmaceuticals, Inc. ($26,280) |
| 2020 | $1,283 | 75 | Allergan, Inc. ($251.52) |
| 2019 | $7,538 | 155 | Novartis Pharmaceuticals Corporation ($4,911) |
| 2018 | $8,858 | 193 | Sunovion Pharmaceuticals Inc. ($5,855) |
| 2017 | $20,903 | 113 | Sunovion Pharmaceuticals Inc. ($17,647) |
All Payment Transactions
820 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: NEUROLOGY | ||||||
| 11/18/2024 | Solventum Corporation | ACTIV.A.C. (Device) | Food and Beverage | Cash or cash equivalent | $20.06 | General |
| Category: Negative Pressure Systems & Dressings | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Neurology | ||||||
| 10/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: PAIN | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neuroscience | ||||||
| 03/21/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: PAIN | ||||||
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: PAIN | ||||||
| 12/21/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: CNS | ||||||
| 12/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: PAIN | ||||||
| 12/18/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: CNS | ||||||
| 11/16/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 151 | 209 | $46,647 | $11,111 |
| 2022 | 7 | 107 | 150 | $40,156 | $12,611 |
| 2021 | 5 | 101 | 168 | $39,667 | $14,887 |
| 2020 | 3 | 58 | 82 | $25,652 | $8,057 |
Total Patients
417
Total Services
609
Medicare Billing
$46,666
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 38 | 76 | $12,938 | $2,506 | 19.4% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 18 | 18 | $8,838 | $2,494 | 28.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 22 | 42 | $6,940 | $1,466 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 22 | 22 | $5,356 | $1,428 | 26.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 13 | 13 | $3,900 | $1,046 | 26.8% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 13 | 13 | $4,540 | $868.17 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,215 | $708.22 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $1,920 | $593.52 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 35 | $12,817 | $4,083 | 31.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,376 | $1,897 | 35.3% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 13 | 13 | $6,383 | $1,869 | 29.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 25 | 46 | $5,474 | $1,655 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 18 | $4,932 | $1,535 | 31.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 13 | 13 | $3,094 | $877.76 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 13 | 13 | $2,080 | $695.55 | 33.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 41 | $13,571 | $5,482 | 40.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 44 | $10,824 | $4,130 | 38.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 12 | $5,376 | $1,925 | 35.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 18 | 37 | $4,403 | $1,384 | 31.4% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 12 | 21 | $3,413 | $1,260 | 36.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 13 | $2,080 | $705.89 | 33.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 42 | $10,332 | $3,273 | 31.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 16 | $7,376 | $2,679 | 36.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 24 | $7,944 | $2,105 | 26.5% |
About Dr. Michael Charlet, M.D
Dr. Michael Charlet, M.D is a Neurology healthcare provider based in Houma, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023082856.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Charlet, M.D has received a total of $68,282 in payments from pharmaceutical and medical device companies, with $323.55 received in 2024. These payments were reported across 820 transactions from 64 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($48,046).
As a Medicare-enrolled provider, Charlet has provided services to 417 Medicare beneficiaries, totaling 609 services with total Medicare billing of $46,666. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Houma, LA
- Active Since 02/16/2006
- Last Updated 07/26/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1023082856
Products in Payments
- NURTEC ODT (Drug) $26,627
- APTIOM (Drug) $24,064
- AIMOVIG (Biological) $4,996
- ONZETRA Xsail (Drug) $2,115
- BOTOX (Biological) $649.93
- Aimovig (Biological) $570.39
- SOLIRIS (Drug) $526.64
- UBRELVY (Drug) $503.08
- Briviact (Drug) $467.39
- LEMTRADA (Drug) $428.65
- TYSABRI (Biological) $392.40
- NUEDEXTA (Drug) $386.53
- NUPLAZID (Drug) $365.21
- Hizentra (Biological) $321.48
- Gamunex-C (Biological) $318.07
- QULIPTA (Drug) $278.50
- NORTHERA (Drug) $225.27
- OXTELLAR XR (Drug) $220.22
- Fycompa (Drug) $217.70
- Vimpat (Drug) $194.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.